If this message is not displayed correctly, please click here.

Dear readers,

welcome to the Christmas newsletter from Dynamic42. We look back on the past year, would like to share our highlights with you and share the latest news from our company.

Click here to go directly to the articles:

We wish you a merry Christmas with your loved ones and a successful and healthy start into the new year!

Do you have any questions about us and our products or requests for this newsletter?
Please do not hesitate to contact us: info@dynamic42.com 

Enjoy reading and see you soon!
Your Dynamic42 Team
A year dedicated to networking and research

The year 2022 finally brought us a large number of personal meetings again, especially at conferences and networking events. We are particularly pleased that research and development in the field of organ-on-chip technology benefit greatly from this exchange and that we have been able to take valuable impressions back to Jena after each event.

A special highlight for us was visiting the EUROoCS in Grenoble (France) as the most important congress of the European Network for Organ-on-a-Chip (OoC). As a board member of the society, our managing director Dr. Martin Raasch is committed to the promotion and further development of OoC research and also stated this at the conference. Furthermore, we presented our research results on different organ- and infection models. Meet us there also next year!

We also expanded our Dynamic42 Academy this year, a project that aims to strengthen the exchange between scientists in the OoC field and to pass on know-how. In the academy sessions participants learn how to handle our biotech chips and how to work with our highly developed in vitro organ models.

And last but not least we were able to take important steps forward in the development of our biotech chips and our organ models. There will also be exciting new pharma collaborations to be announced in early 2023. We will soon report news on both!

Here are a few more highlights:

  • Publication with upcyte technologies: (Download the publication free of charge) We successfully completed a research project about the generation & characterization of expandable human liver sinusoidal endothelial cells and their evaluation in our platform together with upcyte® hepatocytes. 
  • Trademark application: Dynamic42 got confirmed for the registration of four trademarks at the German Patent and Trademark Office.
  • 23rd EUSAAT Congress: We attended the annual conference in Linz where our doctoral student Tim Kaden presented a case study within our liver model and won a Young Scientist Travel Award.
  • Investor Days: We participated in the Investor Days as one of the most important events for presentation and networking in Thuringia. We are always pleased to meet and connect with people who share our path.
  • Coaching-Sessions: This year, Dr. Daniela Böttger-Schmidt and Cassandra Schlangen accompanied us with intensive coaching sessions on the topics of corporate and process management. They provided us with knowledge at a high business level and so we will start into the new year with anticipation and many valuable impulses.

If you would like to stay up to date still in 2023, simply follow us on LinkedIn.

You are also welcome to forward this newsletter to interested parties. Registration is possible here.

The faces of Dynamic42: Our Master's students
Dynamic42 emerged from the university environment. Therefore we know how important and beneficial the close cooperation between companies and young scientists is. It is particularly important to us to invest in the next generation of scientists. Currently, two master's students from Ernst-Abbe University of Applied Sciences (EAH) are supporting and learning with us.

Daria Geilen and Sophie Besser

Both have already completed a Bachelor of Engineering in biotechnology at EAH and are now aiming to complete their degree in pharmaceutical biotechnology.

Since April 2022, they have been researching with our team, in particular their supervisors Anne-Kathrin Bothe, Dr. Martin Raasch, Dr. Katja Graf and Tim Kaden.

Daria is investigating immune-related side effects and the toxicity of therapeutic antibodies in microphysiological organ-on-chip models as part of her thesis and Sophie is researching on the emulation of an inflammatory bowel disease (IBD) model.

Learn more about them and their research projects from our latest blogpost.

D42-News: patent searcher, new website, medac research award

All news at a glance

New competence as patent searcher: Our Co-Founder Dr. Nancy Blaurock-Möller has successfully accomplished a certification as a patent searcher. She completed the programme for scientists and managers from companies and research institutions at the PATONakademie of the State Patent Centre Thuringia. This provides us with new expertise in the field of IP protection, e.g. patent law, IP management and patent documentation.
Visit our new website: Dynamic42's online presence has been shining in new splendour since December. For us, this is the starting signal to begin the coming year tidied up and with new energy. And you can browse our site in a simplified structure and now learn even more about our products and services. Explore now.

Attend the next Organ-on-Chip-Academy:
The next D42-Academ will take place from 6th to 8th February 2023.
Would you like to know more about the Dynamic42 Academy or participate? Write to us a short messgage at info@dynamic42.com with the subject D42-Academy.
Medac Research Award: Four research projects at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) have been awarded the medac Research Award. The award recognises interdisciplinary cooperation between research groups. Our scientist Dr Mai Hoang received the award together with Susann Hartung from the Infections in Haematology/Oncology research group. In cooperation with the department of Applied Systems Biology, they developed an aspergillosis infection model of the lung that is also suitable for the automatic evaluation of microscopic 3D images. This allows various infection scenarios to be observed over several hours without the use of animal experiments. Read the full press release.

Recommended reading:
As lead author, Dr Mai Hoang published the study named "Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infection", for which she was awarded with the medac Research Award. Download publication.
Thank you for your attention and interest. Do you have any questions or suggestions? We welcome your feedback and will be happy to answer your questions. You can also forward this newsletter to interested parties. Information on the protection of your privacy: We guarantee that we will treat the data required for sending, your name and e-mail address, confidentially and will not pass them on or use them for advertising purposes or similar.

If you no longer wish to receive this email (to: unknown@noemail.com), you can unsubscribe free of charge here.
Your contact details will then be deleted from the distribution list.


Dynamic42 GmbH
Martin Raasch, Knut Rennert
Winzerlaer Straße 2
07745 Jena

03641 508 101